Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There…
The post New patent expiration for Schering drug REBETOL appeared first…
Annual Drug Patent Expirations for GLUCOPHAGE+XR Glucophage Xr is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Bristol Myers drug GLUCOPHAGE X…
New patent expiration for Bristol Myers drug GLUCOPHAGE XR Read Post »
Annual Drug Patent Expirations for NIASPAN Niaspan is a drug marketed by Abbvie and is included in one NDA. It is available from eight suppliers. There is one patent protecting…
The post New patent expiration for Abbvie drug NIASPAN appeared firs…
Annual Drug Patent Expirations for PULMICORT+FLEXHALER Pulmicort Flexhaler is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are four patents…
The post New patent expiration for Astrazeneca …
New patent expiration for Astrazeneca drug PULMICORT FLEXHALER Read Post »
Annual Drug Patent Expirations for GIAZO Giazo is a drug marketed by Valeant Pharms Intl and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Valeant Pharms drug GIAZO appeared first on…
New patent expiration for Valeant Pharms drug GIAZO Read Post »
NIASPAN (niacin) Abbvie Patent: 6,469,035 Expiration: Mar 15, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Dr…
Drug Patent Expirations for the Week of March 11, 2018 Read Post »
Annual Drug Patent Expirations for ULTIVA Ultiva is a drug marketed by Mylan Institutional and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Mylan Institutional drug ULTIVA appe…
New patent expiration for Mylan Institutional drug ULTIVA Read Post »
Annual Drug Patent Expirations for SENSIPAR Sensipar is a drug marketed by Amgen and is included in one NDA. It is available from six suppliers. There are three patents protecting…
The post New patent expiration for AMGEN drug SENSIPAR appeared f…
SPRITAM (levetiracetam) Aprecia pharms Patent: 9,463,160 Expiration: Feb 20, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
Th…
Drug Patent Expirations for the Week of February 18, 2018 Read Post »
Annual Drug Patent Expirations for XIMINO Ximino is a drug marketed by Sun Pharm Inds Ltd and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Sun Pharm drug XIMINO appeared first on DrugPat…